0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Dry Eye Syndrome Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-32G15907
Home | Market Reports | Health| Vision Care
Global and India Dry Eye Syndrome Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Dry Eye Syndrome Market Report & Forecast 2023-2029

Code: QYRE-Auto-32G15907
Report
December 2023
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Dry Eye Syndrome Market Size

The global Dry Eye Syndrome revenue was US$ 5385 million in 2022 and is forecast to a readjusted size of US$ 7355.1 million by 2029 with a CAGR of 4.5% during the forecast period (2023-2029).

and India Dry Eye Syndrome Market

and India Dry Eye Syndrome Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
In India, the Dry Eye Syndrome revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.
In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
This report focuses on global and India Dry Eye Syndrome market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Dry Eye Syndrome will continue to grow rapidly in the future.
Global Dry Eye Syndrome Scope and Market Size
Dry Eye Syndrome market is segmented in regional and country, by players, by type and by distribution channel. Companies, stakeholders, and other participants in the global Dry Eye Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by distribution channel for the period 2018-2029.
For India market, this report focuses on the Dry Eye Syndrome market size by players, by Type and by Distribution Channel, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Dry Eye Syndrome Market Report

Report Metric Details
Report Name and India Dry Eye Syndrome Market
Forecasted market size in 2029 US$ 7355.1 million
CAGR 4.5%
Forecasted years 2023 - 2029
Segment by Type
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Others
Segment by Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Dry Eye Syndrome Market size in 2029?

Ans: The and India Dry Eye Syndrome Market size in 2029 will be US$ 7355.1 million.

What is the market share of major companies in and India Dry Eye Syndrome Market?

Ans: Global top five manufacturers hold a share over 60%.

What is the and India Dry Eye Syndrome Market share by type?

Ans: In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%.

What is the and India Dry Eye Syndrome Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Dry Eye Syndrome Market report?

Ans: The main players in the and India Dry Eye Syndrome Market are Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group

What are the Type segmentation covered in the and India Dry Eye Syndrome Market report?

Ans: The Types covered in the and India Dry Eye Syndrome Market report are Artificial Tears, Anti-inflammatory Drugs, Others

1 Study Coverage
1.1 Dry Eye Syndrome Product Introduction
1.2 Global Dry Eye Syndrome Outlook 2018 VS 2022 VS 2029
1.2.1 Global Dry Eye Syndrome Sales in US$ Million for the Year 2018-2029
1.2.2 Global Dry Eye Syndrome Sales in Volume for the Year 2018-2029
1.3 India Dry Eye Syndrome Outlook 2018 VS 2022 VS 2029
1.3.1 India Dry Eye Syndrome Sales in US$ Million for the Year 2018-2029
1.3.2 India Dry Eye Syndrome Sales in Volume for the Year 2018-2029
1.4 Dry Eye Syndrome Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Dry Eye Syndrome in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Dry Eye Syndrome Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Dry Eye Syndrome Market Dynamics
1.5.1 Dry Eye Syndrome Industry Trends
1.5.2 Dry Eye Syndrome Market Drivers
1.5.3 Dry Eye Syndrome Market Challenges
1.5.4 Dry Eye Syndrome Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Dry Eye Syndrome by Type
2.1 Dry Eye Syndrome Market Segment by Type
2.1.1 Artificial Tears
2.1.2 Anti-inflammatory Drugs
2.1.3 Others
2.2 Global Dry Eye Syndrome Market Size by Type
2.2.1 Global Dry Eye Syndrome Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Dry Eye Syndrome Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Dry Eye Syndrome Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Dry Eye Syndrome Market Size by Type
2.3.1 India Dry Eye Syndrome Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Dry Eye Syndrome Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Dry Eye Syndrome Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Dry Eye Syndrome by Distribution Channel
3.1 Dry Eye Syndrome Market Segment by Distribution Channel
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Others
3.2 Global Dry Eye Syndrome Market Size by Distribution Channel
3.2.1 Global Dry Eye Syndrome Sales in Value, by Distribution Channel (2018, 2022 & 2029)
3.2.2 Global Dry Eye Syndrome Sales in Volume, by Distribution Channel (2018, 2022 & 2029)
3.3.3 Global Dry Eye Syndrome Average Selling Price (ASP) by Distribution Channel (2018, 2022 & 2029)
3.3 India Dry Eye Syndrome Market Size by Distribution Channel
3.3.1 India Dry Eye Syndrome Sales in Value, by Distribution Channel (2018, 2022 & 2029)
3.3.2 India Dry Eye Syndrome Sales in Volume, by Distribution Channel (2018, 2022 & 2029)
3.3.3 India Dry Eye Syndrome Average Selling Price (ASP) by Distribution Channel (2018, 2022 & 2029)
4 Global Dry Eye Syndrome Competitor Landscape by Company
4.1 Global Dry Eye Syndrome Market Size by Company
4.1.1 Global Key Manufacturers of Dry Eye Syndrome, Ranked by Revenue (2022)
4.1.2 Global Dry Eye Syndrome Revenue by Manufacturer (2018-2023)
4.1.3 Global Dry Eye Syndrome Sales by Manufacturer (2018-2023)
4.1.4 Global Dry Eye Syndrome Price by Manufacturer (2018-2023)
4.2 Global Dry Eye Syndrome Concentration Ratio (CR)
4.2.1 Dry Eye Syndrome Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dry Eye Syndrome in 2022
4.2.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Dry Eye Syndrome, Product Offered and Application
4.5 Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Dry Eye Syndrome Market Size by Company
4.7.1 Key Players of Dry Eye Syndrome in India, Ranked by Revenue (2022)
4.7.2 India Dry Eye Syndrome Revenue by Players (2018-2023)
4.7.3 India Dry Eye Syndrome Sales by Players (2018-2023)
5 Global Dry Eye Syndrome Market Size by Region
5.1 Global Dry Eye Syndrome Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Dry Eye Syndrome Market Size in Volume by Region (2018-2029)
5.2.1 Global Dry Eye Syndrome Sales in Volume by Region: 2018-2023
5.2.2 Global Dry Eye Syndrome Sales in Volume Forecast by Region (2024-2029)
5.3 Global Dry Eye Syndrome Market Size in Value by Region (2018-2029)
5.3.1 Global Dry Eye Syndrome Sales in Value by Region: 2018-2023
5.3.2 Global Dry Eye Syndrome Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Dry Eye Syndrome Market Size YoY Growth 2018-2029
6.2 Americas Dry Eye Syndrome Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Dry Eye Syndrome Sales in Volume, by Distribution Channel (2018, 2022 & 2029)
6.4 Americas Dry Eye Syndrome Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Dry Eye Syndrome Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Dry Eye Syndrome Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Dry Eye Syndrome Market Size YoY Growth 2018-2029
7.2 EMEA Dry Eye Syndrome Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Dry Eye Syndrome Sales in Volume, by Distribution Channel (2018, 2022 & 2029)
7.4 EMEA Dry Eye Syndrome Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Dry Eye Syndrome Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Dry Eye Syndrome Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Dry Eye Syndrome Market Size YoY Growth 2018-2029
8.2 China Dry Eye Syndrome Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Dry Eye Syndrome Sales in Volume, by Distribution Channel (2018, 2022 & 2029)
9 APAC
9.1 APAC Dry Eye Syndrome Market Size YoY Growth 2018-2029
9.2 APAC Dry Eye Syndrome Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Dry Eye Syndrome Sales in Volume, by Distribution Channel (2018, 2022 & 2029)
9.4 APAC Dry Eye Syndrome Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Dry Eye Syndrome Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Dry Eye Syndrome Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Description and Business Overview
10.1.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Allergan Dry Eye Syndrome Products Offered
10.1.5 Allergan Recent Development
10.2 Alcon
10.2.1 Alcon Company Information
10.2.2 Alcon Description and Business Overview
10.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alcon Dry Eye Syndrome Products Offered
10.2.5 Alcon Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Description and Business Overview
10.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Dry Eye Syndrome Products Offered
10.3.5 Novartis Recent Development
10.4 Santen Pharma
10.4.1 Santen Pharma Company Information
10.4.2 Santen Pharma Description and Business Overview
10.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Santen Pharma Dry Eye Syndrome Products Offered
10.4.5 Santen Pharma Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Description and Business Overview
10.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson Dry Eye Syndrome Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 Bausch & Lomb
10.6.1 Bausch & Lomb Company Information
10.6.2 Bausch & Lomb Description and Business Overview
10.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bausch & Lomb Dry Eye Syndrome Products Offered
10.6.5 Bausch & Lomb Recent Development
10.7 Thea pharmaceuticals
10.7.1 Thea pharmaceuticals Company Information
10.7.2 Thea pharmaceuticals Description and Business Overview
10.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Thea pharmaceuticals Dry Eye Syndrome Products Offered
10.7.5 Thea pharmaceuticals Recent Development
10.8 URSAPHARM
10.8.1 URSAPHARM Company Information
10.8.2 URSAPHARM Description and Business Overview
10.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.8.4 URSAPHARM Dry Eye Syndrome Products Offered
10.8.5 URSAPHARM Recent Development
10.9 SIMILASAN
10.9.1 SIMILASAN Company Information
10.9.2 SIMILASAN Description and Business Overview
10.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SIMILASAN Dry Eye Syndrome Products Offered
10.9.5 SIMILASAN Recent Development
10.10 Akorn
10.10.1 Akorn Company Information
10.10.2 Akorn Description and Business Overview
10.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Akorn Dry Eye Syndrome Products Offered
10.10.5 Akorn Recent Development
10.11 United Laboratories
10.11.1 United Laboratories Company Information
10.11.2 United Laboratories Description and Business Overview
10.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.11.4 United Laboratories Dry Eye Syndrome Products Offered
10.11.5 United Laboratories Recent Development
10.12 Sun Pharmaceutical
10.12.1 Sun Pharmaceutical Company Information
10.12.2 Sun Pharmaceutical Description and Business Overview
10.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Sun Pharmaceutical Dry Eye Syndrome Products Offered
10.12.5 Sun Pharmaceutical Recent Development
10.13 Jianfeng Group
10.13.1 Jianfeng Group Company Information
10.13.2 Jianfeng Group Description and Business Overview
10.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Jianfeng Group Dry Eye Syndrome Products Offered
10.13.5 Jianfeng Group Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Dry Eye Syndrome Industry Chain Analysis
11.2 Dry Eye Syndrome Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Dry Eye Syndrome Production Mode & Process
11.4 Dry Eye Syndrome Sales and Marketing
11.4.1 Dry Eye Syndrome Sales Channels
11.4.2 Dry Eye Syndrome Distributors
11.5 Dry Eye Syndrome Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Dry Eye Syndrome CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Dry Eye Syndrome Market Trends
    Table 3. Dry Eye Syndrome Market Drivers
    Table 4. Dry Eye Syndrome Market Challenges
    Table 5. Dry Eye Syndrome Market Restraints
    Table 6. Global Dry Eye Syndrome Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Dry Eye Syndrome Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Dry Eye Syndrome Sales Growth Rate (CAGR) by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Dry Eye Syndrome Sales Growth Rate (CAGR) by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Dry Eye Syndrome, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Dry Eye Syndrome Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Dry Eye Syndrome Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Dry Eye Syndrome Sales by Manufacturer, (M Units), 2018-2023
    Table 14. Global Dry Eye Syndrome Sales Share by Manufacturer, 2018-2023
    Table 15. Global Dry Eye Syndrome Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 16. Global Dry Eye Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2022)
    Table 18. Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Dry Eye Syndrome, Product Offered and Application
    Table 20. Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Dry Eye Syndrome in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Dry Eye Syndrome Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Dry Eye Syndrome Revenue Share by Players, (2018-2023)
    Table 25. India Dry Eye Syndrome Sales by Players, (M Units), (2018-2023)
    Table 26. India Dry Eye Syndrome Sales Share by Players, (2018-2023)
    Table 27. Global Dry Eye Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Dry Eye Syndrome Sales in Volume by Region (2018-2023) & (M Units)
    Table 29. Global Dry Eye Syndrome Sales in Volume Forecast by Region (2024-2029) & (M Units)
    Table 30. Global Dry Eye Syndrome Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Dry Eye Syndrome Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Dry Eye Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Dry Eye Syndrome Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Dry Eye Syndrome Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Dry Eye Syndrome Sales in Volume by Country (2018-2023) & (M Units)
    Table 36. Americas Dry Eye Syndrome Sales in Volume by Country (2024-2029) & (M Units)
    Table 37. EMEA Dry Eye Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Dry Eye Syndrome Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Dry Eye Syndrome Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Dry Eye Syndrome Sales in Volume by Country (2018-2023) & (M Units)
    Table 41. EMEA Dry Eye Syndrome Sales in Volume by Country (2024-2029) & (M Units)
    Table 42. APAC Dry Eye Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Dry Eye Syndrome Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Dry Eye Syndrome Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Dry Eye Syndrome Sales in Volume by Country (2018-2023) & (M Units)
    Table 46. APAC Dry Eye Syndrome Sales in Volume by Country (2024-2029) & (M Units)
    Table 47. Allergan Company Information
    Table 48. Allergan Description and Business Overview
    Table 49. Allergan Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 50. Allergan Dry Eye Syndrome Product
    Table 51. Allergan Recent Development
    Table 52. Alcon Company Information
    Table 53. Alcon Description and Business Overview
    Table 54. Alcon Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 55. Alcon Dry Eye Syndrome Product
    Table 56. Alcon Recent Development
    Table 57. Novartis Company Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 60. Novartis Dry Eye Syndrome Product
    Table 61. Novartis Recent Development
    Table 62. Santen Pharma Company Information
    Table 63. Santen Pharma Description and Business Overview
    Table 64. Santen Pharma Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 65. Santen Pharma Dry Eye Syndrome Product
    Table 66. Santen Pharma Recent Development
    Table 67. Johnson & Johnson Company Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 70. Johnson & Johnson Dry Eye Syndrome Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. Bausch & Lomb Company Information
    Table 73. Bausch & Lomb Description and Business Overview
    Table 74. Bausch & Lomb Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 75. Bausch & Lomb Dry Eye Syndrome Product
    Table 76. Bausch & Lomb Recent Development
    Table 77. Thea pharmaceuticals Company Information
    Table 78. Thea pharmaceuticals Description and Business Overview
    Table 79. Thea pharmaceuticals Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 80. Thea pharmaceuticals Dry Eye Syndrome Product
    Table 81. Thea pharmaceuticals Recent Development
    Table 82. URSAPHARM Company Information
    Table 83. URSAPHARM Description and Business Overview
    Table 84. URSAPHARM Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 85. URSAPHARM Dry Eye Syndrome Product
    Table 86. URSAPHARM Recent Development
    Table 87. SIMILASAN Company Information
    Table 88. SIMILASAN Description and Business Overview
    Table 89. SIMILASAN Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 90. SIMILASAN Dry Eye Syndrome Product
    Table 91. SIMILASAN Recent Development
    Table 92. Akorn Company Information
    Table 93. Akorn Description and Business Overview
    Table 94. Akorn Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 95. Akorn Dry Eye Syndrome Product
    Table 96. Akorn Recent Development
    Table 97. United Laboratories Company Information
    Table 98. United Laboratories Description and Business Overview
    Table 99. United Laboratories Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 100. United Laboratories Dry Eye Syndrome Product
    Table 101. United Laboratories Recent Development
    Table 102. Sun Pharmaceutical Company Information
    Table 103. Sun Pharmaceutical Description and Business Overview
    Table 104. Sun Pharmaceutical Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 105. Sun Pharmaceutical Dry Eye Syndrome Product
    Table 106. Sun Pharmaceutical Recent Development
    Table 107. Jianfeng Group Company Information
    Table 108. Jianfeng Group Description and Business Overview
    Table 109. Jianfeng Group Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 110. Jianfeng Group Dry Eye Syndrome Product
    Table 111. Jianfeng Group Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Dry Eye Syndrome Customers List
    Table 115. Dry Eye Syndrome Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dry Eye Syndrome Product Picture
    Figure 2. Global Dry Eye Syndrome Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Dry Eye Syndrome Market Size 2018-2029 (US$ Million)
    Figure 4. Global Dry Eye Syndrome Sales 2018-2029 (M Units)
    Figure 5. India Dry Eye Syndrome Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Dry Eye Syndrome Market Size 2018-2029 (US$ Million)
    Figure 7. India Dry Eye Syndrome Sales 2018-2029 (M Units)
    Figure 8. India Dry Eye Syndrome Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Dry Eye Syndrome Market Share in Global, in Volume (M Units) 2018-2029
    Figure 10. Dry Eye Syndrome Report Years Considered
    Figure 11. Product Picture of Artificial Tears
    Figure 12. Product Picture of Anti-inflammatory Drugs
    Figure 13. Product Picture of Others
    Figure 14. Global Dry Eye Syndrome Market Share by Type in 2022 & 2029
    Figure 15. Global Dry Eye Syndrome Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 16. Global Dry Eye Syndrome Sales Market Share in Value by Type (2018-2029)
    Figure 17. Global Dry Eye Syndrome Sales by Type (2018-2029) & (M Units)
    Figure 18. Global Dry Eye Syndrome Sales Market Share in Volume by Type (2018-2029)
    Figure 19. Global Dry Eye Syndrome Price by Type (2018-2029) & (US$/Unit)
    Figure 20. India Dry Eye Syndrome Market Share by Type in 2022 & 2029
    Figure 21. India Dry Eye Syndrome Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 22. India Dry Eye Syndrome Sales Market Share in Value by Type (2018-2029)
    Figure 23. India Dry Eye Syndrome Sales by Type (2018-2029) & (M Units)
    Figure 24. India Dry Eye Syndrome Sales Market Share in Volume by Type (2018-2029)
    Figure 25. India Dry Eye Syndrome Price by Type (2018-2029) & (US$/Unit)
    Figure 26. Product Picture of Hospital
    Figure 27. Product Picture of Retail Pharmacy
    Figure 28. Product Picture of Others
    Figure 29. Global Dry Eye Syndrome Market Share by Distribution Channel in 2022 & 2029
    Figure 30. Global Dry Eye Syndrome Sales in Value by Distribution Channel (2018-2029) & (US$ Million)
    Figure 31. Global Dry Eye Syndrome Sales Market Share in Value by Distribution Channel (2018-2029)
    Figure 32. Global Dry Eye Syndrome Sales by Distribution Channel (2018-2029) & (M Units)
    Figure 33. Global Dry Eye Syndrome Sales Market Share in Volume by Distribution Channel (2018-2029)
    Figure 34. Global Dry Eye Syndrome Price by Distribution Channel (2018-2029) & (US$/Unit)
    Figure 35. India Dry Eye Syndrome Market Share by Distribution Channel in 2022 & 2029
    Figure 36. India Dry Eye Syndrome Sales in Value by Distribution Channel (2018-2029) & (US$ Million)
    Figure 37. India Dry Eye Syndrome Sales Market Share in Value by Distribution Channel (2018-2029)
    Figure 38. India Dry Eye Syndrome Sales by Distribution Channel (2018-2029) & (M Units)
    Figure 39. India Dry Eye Syndrome Sales Market Share in Volume by Distribution Channel (2018-2029)
    Figure 40. India Dry Eye Syndrome Price by Distribution Channel (2018-2029) & (US$/Unit)
    Figure 41. Americas Dry Eye Syndrome Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 42. Americas Dry Eye Syndrome Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 43. Americas Dry Eye Syndrome Sales by Type (2018-2029) & (M Units)
    Figure 44. Americas Dry Eye Syndrome Sales Market Share in Volume by Type (2018-2029)
    Figure 45. Americas Dry Eye Syndrome Sales by Distribution Channel (2018-2029) & (M Units)
    Figure 46. Americas Dry Eye Syndrome Sales Market Share in Volume by Distribution Channel (2018-2029)
    Figure 47. United States Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Canada Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Mexico Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Brazil Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. EMEA Dry Eye Syndrome Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 52. EMEA Dry Eye Syndrome Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 53. EMEA Dry Eye Syndrome Sales by Type (2018-2029) & (M Units)
    Figure 54. EMEA Dry Eye Syndrome Sales Market Share in Volume by Type (2018-2029)
    Figure 55. EMEA Dry Eye Syndrome Sales by Distribution Channel (2018-2029) & (M Units)
    Figure 56. EMEA Dry Eye Syndrome Sales Market Share in Volume by Distribution Channel (2018-2029)
    Figure 57. Europe Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Middle East Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Africa Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. China Dry Eye Syndrome Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 61. China Dry Eye Syndrome Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 62. China Dry Eye Syndrome Sales by Type (2018-2029) & (M Units)
    Figure 63. China Dry Eye Syndrome Sales Market Share in Volume by Type (2018-2029)
    Figure 64. China Dry Eye Syndrome Sales by Distribution Channel (2018-2029) & (M Units)
    Figure 65. China Dry Eye Syndrome Sales Market Share in Volume by Distribution Channel (2018-2029)
    Figure 66. APAC Dry Eye Syndrome Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 67. APAC Dry Eye Syndrome Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 68. APAC Dry Eye Syndrome Sales by Type (2018-2029) & (M Units)
    Figure 69. APAC Dry Eye Syndrome Sales Market Share in Volume by Type (2018-2029)
    Figure 70. APAC Dry Eye Syndrome Sales by Distribution Channel (2018-2029) & (M Units)
    Figure 71. APAC Dry Eye Syndrome Sales Market Share in Volume by Distribution Channel (2018-2029)
    Figure 72. Japan Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. South Korea Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. China Taiwan Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. Southeast Asia Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. India Dry Eye Syndrome Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. Dry Eye Syndrome Value Chain
    Figure 78. Dry Eye Syndrome Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13L12609
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32B20021
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38C19846
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2H20253
Thu Nov 27 00:00:00 UTC 2025

Add to Cart